Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuldeep Singh Sachdeva

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Plos One|July 25, 2014
Impact of introducing the line probe assay on time to treatment initiation of MDR-TB in Delhi, IndiaNeeta Singla, Srinath Satyanarayana, Kuldeep Singh Sachdeva, et al.
Plos One|October 4, 2018
Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, IndiaChandravali Madan, Kamal Kishore Chopra, Srinath Satyanarayana, et al.
BMC Infectious Diseases|June 21, 2019
Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales dataNimalan Arinaminpathy, Deepak Batra, Nilesh Maheshwari, et al.
Plos One|June 6, 2019
What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in IndiaSarang Deo, Pankaj Jindal, Devesh Gupta, et al.
Plos One|October 3, 2012
Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?Sharath Burugina Nagaraja, Ajay M V Kumar, Kuldeep Singh Sachdeva, et al.
Plos One|October 17, 2013
LED-fluorescence microscopy for diagnosis of pulmonary tuberculosis under programmatic conditions in IndiaLord Wasim Reza, Srinath Satyanarayna, Donald A Enarson, et al.
Plos One|October 22, 2014
Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, IndiaPetros Isaakidis, Mrinalini Das, Ajay M V Kumar, et al.
Frontiers in Microbiology|December 9, 2021
Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates-Chennai, India, 2013-2016Sembulingam Tamilzhalagan, Sivakumar Shanmugam, Ashok Selvaraj, et al.
BMC Infectious Diseases|December 29, 2022
Building communities of practice through case-based e-learning to prevent and manage TB among people living with HIV-IndiaReshu Agarwal, Upasna Agarwal, Chinmoyee Das, et al.
The Lancet. HIV|April 7, 2019
Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trialSunil S Solomon, Suniti Solomon, Allison M McFall, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Plos One|July 25, 2014
Impact of introducing the line probe assay on time to treatment initiation of MDR-TB in Delhi, IndiaNeeta Singla, Srinath Satyanarayana, Kuldeep Singh Sachdeva, et al.
Plos One|October 4, 2018
Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, IndiaChandravali Madan, Kamal Kishore Chopra, Srinath Satyanarayana, et al.
BMC Infectious Diseases|June 21, 2019
Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales dataNimalan Arinaminpathy, Deepak Batra, Nilesh Maheshwari, et al.
Plos One|June 6, 2019
What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in IndiaSarang Deo, Pankaj Jindal, Devesh Gupta, et al.
Plos One|October 3, 2012
Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?Sharath Burugina Nagaraja, Ajay M V Kumar, Kuldeep Singh Sachdeva, et al.
Plos One|October 17, 2013
LED-fluorescence microscopy for diagnosis of pulmonary tuberculosis under programmatic conditions in IndiaLord Wasim Reza, Srinath Satyanarayna, Donald A Enarson, et al.
Plos One|October 22, 2014
Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, IndiaPetros Isaakidis, Mrinalini Das, Ajay M V Kumar, et al.
Frontiers in Microbiology|December 9, 2021
Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates-Chennai, India, 2013-2016Sembulingam Tamilzhalagan, Sivakumar Shanmugam, Ashok Selvaraj, et al.
BMC Infectious Diseases|December 29, 2022
Building communities of practice through case-based e-learning to prevent and manage TB among people living with HIV-IndiaReshu Agarwal, Upasna Agarwal, Chinmoyee Das, et al.
The Lancet. HIV|April 7, 2019
Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trialSunil S Solomon, Suniti Solomon, Allison M McFall, et al.
Pageof 5